Portal LIS – Localizador de Informação em Saúde

http://www.pbtc.org/

The PBTC is a multidisciplinary cooperative researh organization devoted to the study of correlative tumor biology and new therapies for primary CNS tumors of childhood. The National Cancer Institute established and funded a nine-institution Pediatric Brain Tumor Consortium (PBTC). Each participating member institution was selected by competitive review by a NCI special study section based on their extensive experience with pediatric brain tumor clinical trials and ability to support novel correlative studies.

Originator(s): Baylor College of Medicine, Children`s Hospital of Philadelphia,, Children`s Hospital National Medical Center, Duke University, Harvard University, National Cancer Institute, North American Brain Tumor Coalition, St. Jude Children`s Research Hospital, The University of California at San Francisco, University of Pittsburgh, The University of Washington.

Resource added in: 07/10/2002

Objective: The primary objective of the PBTC is to rapidly conduct novel phase I and II clinical evaluations of new therapeutic drugs, intrathecal agents, delivery technologies, biological therapies, and radiation treatment strategies in children age 0 - 21 years of age with primary CNS tumors.

Available languages: English

Astrocytoma, Glioma, Drug Therapy, Radiotherapy, General Surgery, Recurrence, Classification, Pediatrics, Child, Adolescent, Neoplasms, Drug Therapy, Radiotherapy, General Surgery, Clinical Protocols, Research Design, Child, Adolescent, Clinical Trials Data Monitoring Committees, Research Groups, Pediatrics, Neoplasmas cerebrales, Estadificación de Neoplasmas, recurrencia local del neoplasma, Neoplasmas del Sistema Nervioso Central, Ensayos Clínicos, Ensayos Clínicos Fase II, Ensayos Clínicos Fase III, Estudios Multicéntricos, Neoplasmas Cerebrales